Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13

Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which are customarily used to manage schizophrenia sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Falvella, Ana Caroline Brambilla, Smith, Bradley Joseph, Silva-Costa, Licia C., Valença, Aline G. F., Crunfli, Fernanda, Zuardi, Antonio W., Hallak, Jaime E., Crippa, José A., de Almeida, Valéria, Martins-de-Souza, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193732/
https://www.ncbi.nlm.nih.gov/pubmed/34122009
http://dx.doi.org/10.3389/fnmol.2021.673144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193732/
https://www.ncbi.nlm.nih.gov/pubmed/34122009
http://dx.doi.org/10.3389/fnmol.2021.673144

Ejemplares similares